Department of Pharmacodynamics, Meiji Pharmaceutical University, Tokyo, Japan.
J Neurochem. 2010 May;113(4):990-1001. doi: 10.1111/j.1471-4159.2010.06669.x. Epub 2010 Mar 4.
We investigated the regulatory pathways responsible for agonist-induced internalization and down-regulation of G(q) protein-coupled histamine H(1)-receptors in Chinese hamster ovary cells. Histamine-induced internalization and down-regulation of H(1)-receptors were detected as the loss of [(3)H]mepyramine binding sites on intact cells accessible to hydrophilic and hydrophobic H(1)-receptor antagonists, pirdonium and mepyramine, respectively. Pretreatment of cells with 0.1 mM histamine for 30 min at 37 degrees C induced internalization as well as down-regulation of H(1)-receptors, both of which were inhibited either in the presence of an inhibitor against G protein-coupled receptor kinases (ZnCl(2)) or under hypertonic conditions where clathrin-dependent endocytosis is known to be inhibited, but were not affected by inhibitors against caveolae/raft-dependent endocytosis (filipin and nystatin). Down-regulation of H(1)-receptors, but not their internalization, was inhibited by protein kinase C inhibitors (chelerythrin or GF109203X), a ubiquitin E1 inhibitor (UBEI-41) and proteasome inhibitors (lactacystin and MG-132). Neither a Ca(2+)/calmodulin-dependent protein kinase II inhibitor (KN-62) nor lysosomal protease inhibitors (E-64, leupeptin, chloroquine and NH(4)Cl) affected the internalization and down-regulation of H(1)-receptors. These results suggest that H(1)-receptors internalize upon agonist stimulation via G protein-coupled receptor kinase/clathrin-dependent but caveolae/raft-independent mechanisms and are delivered to proteasomes, preferentially to lysosomes, for their prompt down-regulation.
我们研究了负责激动剂诱导的 G(q) 蛋白偶联组胺 H(1)-受体内化和下调的调节途径在中国仓鼠卵巢细胞。组胺诱导的 H(1)-受体内化和下调被检测为亲水性和疏水性 H(1)-受体拮抗剂,分别为 pirdonium 和 mepyramine,可用于完整细胞的 [(3)H]mepyramine 结合位点的丧失。用 0.1 mM 组胺在 37°C 预处理细胞 30 分钟诱导 H(1)-受体的内化和下调,这两者都被 G 蛋白偶联受体激酶抑制剂 (ZnCl(2)) 存在时或在高渗条件下抑制,其中网格蛋白依赖性内吞作用已知被抑制,但不受 caveolae/raft 依赖性内吞作用抑制剂 (filipin 和 nystatin) 的影响。H(1)-受体的下调,但不是它们的内化,被蛋白激酶 C 抑制剂 (chelerythrin 或 GF109203X)、泛素 E1 抑制剂 (UBEI-41) 和蛋白酶体抑制剂 (lactacystin 和 MG-132) 抑制。钙/钙调蛋白依赖性蛋白激酶 II 抑制剂 (KN-62) 和溶酶体蛋白酶抑制剂 (E-64、亮肽素、氯喹和 NH(4)Cl) 均不影响 H(1)-受体的内化和下调。这些结果表明,H(1)-受体在激动剂刺激下通过 G 蛋白偶联受体激酶/网格蛋白依赖性但 caveolae/raft 独立的机制内化,并被递送至蛋白酶体,优先递送至溶酶体,以进行快速下调。